On this page
- Quick answer
- Patents and CDSCO approval are separate tracks
- What can be patented, and what gets in the way
- Searching before you draft
- Drafting a device specification
- Freedom to operate before launch
- Filing abroad
- A worked example: a low-cost neonatal CPAP device
- Common mistakes
- Checklist
- How MYCrave can help
- Plan the patent and the dossier together
- Frequently asked questions
Medical device founders carry two sets of paperwork. One goes to the Central Drugs Standard Control Organisation, to show the device is safe and performs as claimed. The other goes to the Patent Office, to protect what is new about it. The two systems do not talk to each other, and confusing them is one of the most expensive mistakes in the sector.
A CDSCO licence does not stop a competitor copying your device. A granted patent does not let you sell it, and it does not mean nobody else's patent covers it. This guide sets out how to approach the patent side: what you can protect, how to search, how to write the claims, and when to check that you are free to launch.
Quick answer
Medical devices, instruments, implants, wearables, diagnostic kits and the processes for making them can be patented in India if they are new, inventive and industrially applicable. What cannot be patented is a method of treating or diagnosing a human being or animal (section 3(i)), so the device, the system or the kit is claimed instead. Search before drafting, using classification codes such as A61B, A61M and A61F alongside clinical literature. File before any conference presentation, publication or public trial. Before launch, run a separate freedom-to-operate search on the markets where you will sell. Regulatory approval under the Medical Devices Rules, 2017 is a different process and does not affect patent rights either way, although section 107A lets you use a patented invention to generate data for regulatory submissions.
Patents and CDSCO approval are separate tracks
Under the Medical Devices Rules, 2017, devices are grouped by risk, from Class A (low risk) to Class D (high risk), and need registration or licensing before they are imported, manufactured or sold. The regulator asks whether the device is safe and works. It does not ask whether it infringes a patent, and it does not grant any exclusive right.
The Patent Office asks the opposite questions: is the invention new, inventive and capable of industrial application, and is it described well enough to be reproduced? It does not care whether the device is approved.
The two tracks touch in a few places:
- Section 107A says that making, using, selling or importing a patented invention solely for uses reasonably related to developing and submitting information required by a law regulating the product is not infringement. You can build and test a device that uses a patented feature to prepare a regulatory dossier. You cannot sell it on the market.
- Timing. Clinical evaluation can take longer than patent prosecution. A patent granted early, on a design that changes during trials, may not cover the version that gets approved. Plan the specification to cover the variants you might end up with.
- Disclosure. Regulatory submissions are confidential, but clinical trial registrations, investigator meetings and conference abstracts may not be. File the patent application first.
What can be patented, and what gets in the way
The patentable side is broad: the device and its components, implants and their coatings, single-use disposables, wearable monitors, surgical instruments, diagnostic kits and reagents, drug-device combinations, manufacturing processes, and device software that produces a technical effect.
The obstacles are specific, and each needs planning at the drafting stage.
| Provision | What it excludes | How device applicants deal with it |
|---|---|---|
| Section 3(i) | Medicinal, surgical, curative, prophylactic, diagnostic, therapeutic or other treatment processes for humans, and similar treatment of animals | Claim the device, system, kit or manufacturing process. Write functional features into device claims ("configured to") rather than into method-of-use claims |
| Section 3(f) | Mere arrangement or duplication of known devices each working independently in a known way | Show the parts interact to give a combined effect. Common for kits and multi-component systems |
| Section 3(k) | Computer programmes per se and algorithms | Tie device software to a technical effect on the hardware or the physiological signal processing |
| Section 3(d) | New forms of known substances without enhanced efficacy | Relevant to drug-eluting coatings and drug-device combinations; include comparative data |
| Section 3(c) | Discovery of a scientific principle or a substance occurring in nature | Claim the technical application, not the finding |
Searching before you draft
A device search has two halves: patents and clinical or engineering literature. Devices are often described in journal articles, conference posters and regulatory summaries long before anyone files a patent.
Patent classification. The International Patent Classification puts most medical devices in class A61. The groups you will meet most are:
- A61B: diagnosis, surgery and identification, including surgical instruments, endoscopes and physiological measurement.
- A61M: devices for introducing media into or onto the body, such as syringes, catheters, infusion pumps, inhalers and respiratory devices.
- A61F: implants, prostheses, orthopaedic devices, bandages and dressings, and devices for the eye and ear.
- A61N: electrotherapy, magnetotherapy and radiation therapy.
- G16H: healthcare informatics, for software-led devices.
Use IPCPUB to find the right subgroup, then search it on InPASS for Indian filings and on Espacenet or Google Patents worldwide. Our prior art search guide explains how to build the search.
Non-patent sources. PubMed for clinical literature, the Clinical Trials Registry of India and international trial registries, regulatory databases such as the US FDA's device clearance records (which often describe predicate devices in detail), manufacturer instructions for use and conference proceedings.
Your own disclosures. Check whether anyone on your team has already presented, published or demonstrated the device. Indian law gives only narrow grace periods. Section 31 protects certain disclosures, such as display at a notified exhibition or a paper read before a learned society, if you file within twelve months, and since 2024 that claim is made on Form 31 (rule 29A). Section 32 protects public working for reasonable trial within one year before the priority date in limited cases. Neither covers an ordinary journal article or a sales demonstration.
Drafting a device specification
Describe the clinical problem in technical terms. "Neonatal CPAP units need a compressed air supply that rural hospitals lack" is a technical problem. "Babies deserve better care" is not.
Claim the structure. The device claim should recite the components and how they relate, plus the features that make the device work: the valve geometry, the sensor placement, the material property, the control logic. Keep features that only reflect the prototype, such as the brand of pump or the colour of the housing, out of claim 1.
Put function into the device, not the treatment. You cannot claim "a method of delivering oxygen to a neonate". You can claim "a respiratory support device comprising... a controller configured to maintain the delivered oxygen fraction between 21% and 60% in response to the flow sensor signal".
Think in kits and systems. A disposable cartridge used with a reusable base unit can be claimed as the cartridge alone, the base unit alone and the system, so that a competitor selling compatible cartridges is still caught. Make sure the combination has a real interaction to answer section 3(f).
Include ranges and alternatives. Dimensions, pressures, flow rates and materials should be described as ranges with preferred values, and alternatives should be named. These give you room to amend under section 59 if the examiner finds close prior art, and they make design-arounds harder.
Support with data, carefully. Bench test and animal study results strengthen inventive step arguments. Do not delay filing to wait for clinical results, and do not publish those results before filing.
Check inventorship and ownership. Clinicians often contribute key ideas. If a doctor employed by a hospital is a co-inventor, the hospital may have rights. Settle assignments in writing before filing.
Freedom to operate before launch
Patentability asks whether you can get a patent. Freedom to operate asks whether you can sell your product without infringing someone else's. They are different searches with different answers. A device can be patentable because one feature is new, and still infringe an earlier patent that covers the rest.
Run an FTO before you commit to tooling and before launch, for each country where you will make or sell the device. Look at granted patents in force and at published applications that could still be granted. For every relevant patent, compare the claims feature by feature with your product, check the legal status (renewal fees paid, term remaining) and decide on a response: design around, license, challenge the patent, or accept the risk with eyes open. Our freedom-to-operate guide covers the method.
Filing abroad
Most device companies sell, or hope to sell, outside India. The Paris Convention gives you twelve months from your first filing to file abroad with priority, and a PCT application keeps over 150 countries open for up to 30 months from priority. If the inventors are resident in India, section 39 requires you to file in India first and wait six weeks, or obtain permission on Form 25, before filing abroad. Our guide on filing outside India explains the sequence.
A worked example: a low-cost neonatal CPAP device
The example is hypothetical. A Bengaluru startup has built a bubble CPAP device for district hospitals that runs from an oxygen concentrator, without the compressed air supply most units need.
- What not to claim. "A method of providing respiratory support to a premature infant" falls under section 3(i).
- Search. The search finds bubble CPAP devices going back decades, several air-entrainment blenders and a journal article on low-cost CPAP for low-resource settings. The new feature is a passive venturi blender that mixes room air with concentrator oxygen at a stable ratio across the flow range the device uses, without a compressor.
- Claims. Claim 1 covers a CPAP device with an oxygen inlet, a venturi blender of defined geometry, a humidifier and a water-seal pressure generator, where the blender maintains a defined oxygen fraction range across a defined flow range. Dependent claims cover the blender geometry, the humidifier design and a disposable patient circuit. A separate claim covers the blender as a component, so it is protected if sold on its own.
- FTO. The FTO search finds a granted Indian patent on a humidification chamber with a particular baffle arrangement. The startup changes its humidifier design before tooling, and records why the new design falls outside the claims.
Common mistakes
- Presenting the device at a medical conference, or publishing a case series, before filing.
- Drafting method-of-treatment claims that section 3(i) will strike out.
- Assuming a CDSCO licence means the device does not infringe anyone's patent.
- Running a patentability search and treating it as an FTO.
- Claiming the prototype in claim 1, with every component and material.
- Forgetting the software, or claiming it in a way that invites a section 3(k) objection.
- Leaving clinician co-inventors and hospital ownership unresolved until a licensing deal.
Checklist
- No public disclosure has happened, or any disclosure falls within section 31 or 32 and has been documented.
- The search covered the relevant A61 groups and clinical and regulatory literature.
- Claims are directed to the device, system, kit, components or manufacturing process, not to treatment.
- Functional features are written into device claims.
- Ranges, alternatives and variants likely to emerge during clinical evaluation are described.
- Combination and kit claims show interaction, to answer section 3(f).
- Inventorship and assignments, including clinicians, are settled in writing.
- An FTO for each launch market is planned before tooling.
- Foreign filing dates and section 39 are diarised.
How MYCrave can help
MYCrave Consultancy & Services works on medical device inventions within its patent registration and freedom-to-operate practices, with 8,000+ prior art searches and a Registered Patent Agent (No. 5509) on record:
- Free prior art search across patents and clinical literature before drafting.
- Specification drafting that keeps device claims clear of section 3(i), with a complete specification starting at ₹12,750 in professional fees.
- Freedom-to-operate analysis for launch markets, with claim charts and design-around options.
- PCT filing from ₹15,500 in professional fees, with section 39 compliance.
Plan the patent and the dossier together
The best device patents are written by people who know what the regulator will ask, and the best regulatory plans are made by people who know what the patent covers. Search early, file before you present, claim the device rather than the treatment, and check your freedom to operate before money goes into moulds and machines.
Developing a medical device?
Share your device concept, drawings and launch markets. We will run the prior art search, plan the claims around section 3(i) and flag any freedom-to-operate risk before you tool up. Call +91 76006 90996 or write to info@mycrave.co.in.
Plan your device IPFrequently asked questions
Can a medical device be patented in India?
Does CDSCO approval give me any patent protection?
Can I use a patented device to run trials for regulatory approval?
Should I present my device at a conference before filing?
What is the difference between a patentability search and an FTO search?
Can I patent the software in my medical device?
Talk to a MYCrave IP expert. Free initial consultation, complete confidentiality.
Book a ConsultationAbout this guide
- The Patents Act, 1970, sections 2(1)(j), 3(d), 3(f), 3(i), 3(k), 10(4), 31, 32, 39 and 107A
- The Patents Rules, 2003, rule 29A and First Schedule, as amended by the Patents (Amendment) Rules, 2024
- The Medical Devices Rules, 2017 (Central Drugs Standard Control Organisation)
- WIPO, International Patent Classification (IPCPUB), class A61
- Indian Patent Office public search, InPASS
Patent law checked against the Patents Act, 1970 and the Patents Rules, 2003 as amended in March 2024. Regulatory requirements for medical devices are set by CDSCO and change separately; confirm them with the regulator. Confirm the patent position with the Office of the Controller General of Patents, Designs and Trade Marks.
Spotted an error? Tell us at info@mycrave.co.in and we will correct it. How we research, review and update this library is set out in our editorial policy. This guide is general information about Indian IP law and procedure, not advice on your specific matter.